The notices it replaced
- Reissues: PA-22-177 PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 2 steps back: PA-21-260 PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 3 steps back: PA-20-262 PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 4 steps back: PA-19-273 PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required
- 5 steps back: PA-18-573 PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Replaced by PA-24-246.
Who won it before
458 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $313,077,936 in first-year total cost, median $681,556.
Most frequent study sections
- Special Emphasis Panel[ZRG1 RPHB-Z (10)]45
- Special Emphasis Panel[ZRG1 RPHB-Y (12)]43
- Special Emphasis Panel[ZRG1 SCIL-D (10)]34
- Special Emphasis Panel[ZRG1 CCHI-J (10)]29
- Special Emphasis Panel[ZRG1 RPHB-D (16)]20
Most frequent institutions
- OREGON RES BEHAVIORAL INTERVENTION STRAT15
- MINNESOTA HEALTHSOLUTIONS CORPORATION10
- ISA ASSOCIATES, INC.8
- BARRON ASSOCIATES, INC.6
- FLINT REHABILITATION DEVICES6
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Hub4Smell: Advancing Human Olfactory Research through Digital Innovation and Community Engagement1R44DC022498-01 | KEDZIORA, RICHARDLUCAS-SCHNARRE, PATRICIAPARMA, VALENTINA | ESTENDA SOLUTIONS, INC., PA | $1,372,201 | ZRG1 |
| 2025 | Point of Care maternal milk concentration device optimizing neonatal growth with targeted nutrition support: Establishing clinical evidence of benefit as an alternative to milk sourced fortification2R44HD110306-03 | NELSON, ELIZABETH RANDALL | MOTHER'S MILK IS BEST, INC., MA | $1,175,845 | ZRG1 |
| 2025 | Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors1R44CA297977-01 | BECK, SUSAN LGOLD, MELANIE ARIANE | 5 POINT APP, NY | $1,019,587 | ZRG1 |
| 2025 | Zip-stitch for Laparoscopic Hysterectomy - Clinical Validation2R44HD104539-03 | MAZZUCCO, DAN C | ZSX MEDICAL, LLC, PA | $1,000,000 | ZRG1 |
| 2025 | Development of LNS8801 for cutaneous melanoma patients who cannot tolerate immunotherapy1R44CA297994-01 | GARYANTES, TINA | LINNAEUS THERAPEUTICS INC, NJ | $999,960 | ZRG1 |
| 2025 | Virtual Activities of Living for Occupational Rehabilitation2R44HD107718-02 | ADAMS, RICHARD J. | BARRON ASSOCIATES, INC., VA | $925,658 | ZRG1 |
| 2025 | A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination2R44MH126793-03 | BRUNS, ERIC J.DEROSIER, MELISSA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $866,289 | ZRG1 |
| 2025 | Intervention for Chronic Insufficient Sleep in Young Adult Cancer Patients and Survivors2R44CA254637-02 | GREENBERG, DANIEL JGRONINGER, J. HUNTER | MEDIA REZ, LLC, DC | $734,690 | ZRG1 |
| 2025 | Utilizing Smart Speaker Technology to Deliver Parenting Education Support to Parents of Young Children2R44HD101190-02 | METZLER, CAROL WSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $712,096 | ZRG1 |
| 2025 | A Novel Prosthetic Ankle Joint with Swing Phase Dorsiflexion and Terrain Adaptation1R44HD117546-01 | BARTLETT, HARRISON LOGAN | LITTLE ROOM INNOVATIONS, LLC, MI | $624,165 | ZRG1 |
| 2025 | Unmute's CARE framework: A Novel Approach to Strengthen the Therapeutic Alliance and Reduce Treatment Disparities1R43MH139271-01 | CHANG, DORIS FLEUNG, COLLEEN | UNMUTE ENTERPRISE INC, MA | $461,776 | ZRG1 |
| 2025 | Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer1R43CA297808-01 | ARNOLD, RENEE J.G | ARNOLD CONSULTANCY AND TECHNOLOGY, LLC, NY | $357,371 | ZRG1 |
| 2025 | STEM As I Am: A culturally relevant media-enhanced tool for engaging Black middle school students and their families in STEM1R43MD020230-01 | MARQUEZ, JESSIESMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $306,872 | ZRG1 |
| 2025 | Wearable Heat Related Injury Risk Analysis (WHERA) system Resubmission1R43OH012965-01A1 | ZHUKOV, DMITRIY V | CHROMOLOGIC, LLC, CA | $306,469 | ZRG1 |
| 2025 | A Unique Body-Powered Terminal Device with Enhanced Grasping Capabilities for Individuals with Upper Limb Loss1R43HD115423-01A1 | BARTLETT, HARRISON LOGAN | LITTLE ROOM INNOVATIONS, LLC, MI | $304,906 | ZRG1 |
| 2025 | Lowering Economic, Infrastructure, & Physical Barriers with Noninvasive, Wireless Telemedicine Cerebrospinal Fluid Flow Sensing for Pediatric Hydrocephalus Patients in Puerto Rico1R43MD020017-01A1 | SOMERA, ANNA LISA | RHAEOS, INC., IL | $298,772 | ZRG1 |
| 2025 | Validating Terra, a device for closed-loop hot-flash cooling relief and sleep improvement1R43AG087901-01A1 | SISON, EMILIO | AMIRA HEALTH INC., CA | $277,391 | ZRG1 |
| 2024 | Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis2R44AG061985-06 | LEWIS, GEORGE KENNETH | ZETROZ SYSTEMS, LLC, CT | $2,196,474 | ZRG1 |
| 2024 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery2R44HL160434-02 · under PA-22-177 | SEWARD, KIRK | MERCATOR MEDSYSTEMS, INC., CA | $1,636,379 | ZRG1 |
| 2024 | At-home, ultrasonic device for treatment of vulvovaginal atrophy1R44HD115491-01A1 | ROCKWEILER, HOLLY | MADORRA, INC., OR | $1,514,498 | ZRG1 |
| 2024 | Development and commercialization of support tools to promote safety and adoption of pharmacist prescribed contraceptive services.2R44HD110346-02A1 | KUCEK, MARY | OVARYIT, LLC, PA | $1,341,329 | ZRG1 |
| 2024 | Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients1R44HL170779-01A1 | JOHNSTON, KIMBERLY ANNE | INNOVATIVE BIOTHERAPIES, INC., MI | $1,314,026 | ZRG1 |
| 2024 | A Digital Health Technology to Prevent Family Violence and Improve Child Mental Health2R42MH132191-02 | MAURICIO, ANNE MARIEREITER, LISA ANNSTORMSHAK, ELIZABETH A | NORTHWEST PREVENTION SCIENCE INC, OR | $1,257,942 | ZRG1 |
| 2024 | Surgical drape with a releasable acrylic adhesive for atraumatic negative pressure wound therapy1R44EB036280-01 | ROSING, HOWARDWINCHELL, ROBERT JOHN | GLOBAL BIOMEDICAL TECHNOLOGIES, LLC, FL | $1,216,704 | ZRG1 |
| 2024 | SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS2R44HL151025-02A1 | BOIRE, TIMOTHY C | VENOSTENT, INC., TX | $1,212,392 | ZRG1 |
| 2024 | A comprehensive imaging solution for dense breast cancer screening and diagnostics2R44CA261381-02A1 | GHAZI, PEYMON | MALCOVA INC, CA | $1,134,189 | ZRG1 |
| 2024 | Placement Success Predictor: Using Site-Customized Machine Learning Models to Predict the Best Level of Care Placement for Each Child's Behavioral Health Needs2R44MH125486-02A1 · under PA-22-177 | TRUDEAU, KIMBERLEE JEAN | OUTCOME REFERRALS INC, MA | $1,110,421 | ZRG1 |
| 2024 | A Novel Instrument to Address Freezing of Gait in Parkinson's Patients2R44AG074825-02 | CLARK, BRIAN R | BARRON ASSOCIATES, INC., VA | $1,075,644 | ZRG1 |
| 2024 | A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration2R44EY031202-04A1 | BHUIYAN, ALAUDDINSMITH, ROLAND THEODORE | IHEALTHSCREEN, INC., NY | $1,049,010 | ZRG1 |
| 2024 | Leveraging Interactive Digital Technology to Increase Access to Family-Based Behavioral Treatment for Childhood Obesity1R44HL176464-01A1 | DEROSIER, MELISSA E.EPSTEIN, LEONARD HWILFLEY, DENISE ELLA | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $1,044,896 | ZRG1 |
| 2024 | Development of a novel, cost-effective gait training device utilized at home for the neurological patient population1R44HD113451-01A1 | HARTMAN, JULIETAYLOR, BEN | HEALING INNOVATIONS INC, TN | $1,032,031 | ZRG1 |
| 2024 | Hormonal contraceptive Access via Pharmacist-Prescribing Implementation package (HAPPI)2R44DP006691-02 | MEREDITH, ASHLEY HNEWLON, JENNY LEIGHRAFIE, SALLY | EMPOWERX, INC., CA | $1,014,644 | ZRG1 |
| 2024 | A novel digital platform for measurement-based peer supervision of non-specialist providers conducting brief psychological interventions2R44MH130305-02 | HO, Y. XIANLESH, NEAL | DIMAGI, INC., MA | $1,014,530 | ZRG1 |
| 2024 | Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer1R44CA295173-01 | MEDAROVA, ZDRAVKA O | TRANSCODE THERAPEUTICS, INC., MA | $1,011,207 | ZRG1 |
| 2024 | Clinical Trial to Demonstrate Impact of an AI-enabled 3D Ultrasound-based Guidance System in Reducing Arteriovenous Fistula Cannulation Injury and Improving Patient Quality of Life2R44DK131644-03 | COOPER, RANDYKANG, XIN | SONAVEX, INC., MD | $1,000,001 | ZRG1 |
| 2024 | Collagen-based tissue guidance biofabric for treatment of stress urinary incontinence in women2R44HD102241-03 | SHANKAR, SUBBA | COLLAMEDIX INC., OH | $1,000,000 | ZRG1 |
| 2024 | Long-acting PTH for hypoparathyroidism1R44DK138647-01 · under PA-22-177 | HALES, LAURA M | EXTEND BIOSCIENCES, INC., MA | $999,615 | ZRG1 |
| 2024 | A NOVEL PRECISION MEDICINE APPROACH FOR OBESITY: A RANDOMIZED, MULTI-CENTER TRIAL1R44DK138619-01 · under PA-22-177 | BAGNALL, MARK | PHENOMIX SCIENCES, LLC, CA | $996,003 | ZRG1 |
| 2024 | CTO1681 to prevent and mitigate cytokine release syndrome in CAR T-cell recipients1R44CA287634-01A1 | BERTOLINO, ARTHUR P | CYTOAGENTS, INC., PA | $994,859 | ZRG1 |
| 2024 | Development and Commercialization of a weight monitoring platform for wheelchair users1R44HD114504-01A1 | PEARLMAN, JONATHAN LSHAABAN, SAMI | NURELM E-BUSINESS SOFTWARE, PA | $987,365 | ZRG1 |
| 2024 | Development, Feasibility, and Acceptability of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical EducationActivities for 3-5 Grade Elementary Students2R44DP006743-02 | JOHNSON-SHELTON, DEBORAHRICCI, JEANETTE | SAAVSUS, INC., OR | $981,512 | ZRG1 |
| 2024 | Digital Aftercare Assessed: An Evaluation of the Pink Cloud Application in Post-Treatment Substance Use Disorder Support.1R44DA061662-01 | LABRIE, JOSEPH W.VARUGHESE, JASON | PINK CLOUD LLC, CA | $980,000 | ZRG1 |
| 2024 | Efficacy of a Virtual Reality Neuroscience-based Therapy for Chronic Low Back Pain2R44NR017575-02A1 | BAEUERLE, TASSILOCEKO, MARTAWAY, AMANDA | COGNIFISENSE, INC., CA | $977,764 | ZRG1 |
| 2024 | Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss2R44DC018760-02A1 | KING, CURTIS SCOTTRAJGURU, SUHRUD M. | RESTOREAR DEVICES, LLC, MT | $970,535 | ZRG1 |
| 2024 | mHealth app for caregiver instruction in manual therapy for chemotherapy-induced peripheral neuropathy2R44CA268678-02A1 | COLLINGE, WILLIAM B.TOFTHAGEN, CINDY | COLLINGE AND ASSOCIATES, OR | $968,308 | ZRG1 |
| 2024 | MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke1R44AG090216-01 | RUSSELL, IAN MILES | FLINT REHABILITATION DEVICES, CA | $950,785 | ZRG1 |
| 2024 | Intervention to Help Orient Men to Excel (IN-HOME): A culturally appropriate CHW training program to reduce minority caregiver burden2R44MD018249-02 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $925,820 | ZRG1 |
| 2024 | Home-Based Leg Dexterity Trainer for Management of Knee Osteoarthritis1R44AG090114-01 | VALERO, ERIKA | NEUROMUSCULAR DYNAMICS, LLC, CA | $900,209 | ZRG1 |
| 2024 | Phase 1 Safety, Pharmacokinetic study followed by Phase 2a Proof-of-Concept study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in neonates1R44HD112276-01A1 · under PA-22-177 | ACHARYA, SUCHISMITA | AYUVIS RESEARCH, INC., TX | $895,365 | ZRG1 |
| 2024 | Closed Loop Electrical Muscle Stimulation System (CL-EMS) with improved safety for ICU environment to mitigate ICU Acquired Weakness2R44EB033725-02 | HASSAN, OUSSAMA | HEALTH DISCOVERY LABS LLC, TX | $874,061 | ZRG1 |
| 2024 | Comparison of convection enhanced delivery systems in a randomized controlled clinical study of recurrent Grade 3-4 glioma patients1R44CA295197-01 | ABRAMOV, VASILIY | CREOSALUS, INC., KY | $857,315 | ZRG1 |
| 2024 | Quédate Tranquila: A Mobile, Web-based Stress Management Intervention for Hispanic Women2R44MD017105-02 | RIOS, DEBRA | ISA ASSOCIATES, INC., VA | $842,935 | ZRG1 |
| 2024 | A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy2R44CA268700-02A1 | AUSTIN, DANA E.GELBER, COHAVA | SERPIN PHARMA, LLC, VA | $838,708 | ZRG1 |
| 2024 | Safety and Efficacy Trial of the ColoSeal ICD System for the Treatment of Rectal Cancer Patients1R44CA287615-01A1 | FONG, KENTON DODYAN | SAVAGE MEDICAL, CA | $838,162 | ZRG1 |
| 2024 | IVOS Medical: Intubation, Optimized.2R44HL164325-02 | PUNSALAN, GABRIEL | IVOS MEDICAL, INC., CA | $824,627 | ZRG1 |
| 2024 | Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care2R44DA056259-02 · under PA-22-177 | DENNIS, MICHAEL L.GILES, MICHAEL | SONARA HEALTH INC, TX | $812,322 | ZRG1 |
| 2024 | Walk with Me (WWM) for Perinatal Grief2R44MH126788-02 | CIOFFI, CAMILLE CSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $803,332 | ZRG1 |
| 2024 | A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Specific T Cells (MT-601) Administered to Patients with Metastatic Pancreatic Cancer following frontline FOLFIRINOX1R44CA295168-01 | SMAGLO, BRANDONVERA, JUAN FERNANDO | MARKER THERAPEUTICS, INC., TX | $674,275 | ZRG1 |
| 2024 | A Phase 1 Study of Patient-Derived Multi-Tumor-Associated Antigen Specific T Cells (MT-601) Administered to Patients with Relapsed Non-Hodgkin Lymphoma1R44CA291521-01 | VERA, JUAN FERNANDO | MARKER THERAPEUTICS, INC., TX | $665,000 | ZRG1 |
| 2024 | Computer Guided Microwave Liver Ablation1R44CA287803-01 · under PA-22-177 | BORSIC, ANDREA | NE SCIENTIFIC, INC., MA | $603,206 | ZRG1 |
| 2024 | Phase IIB Clinical and Nonclinical Testing of Soft Spring Continence Pessary for Women, in Support of FDA 510(k) Clearance Requirements2R44HD105574-03 · under PA-22-177 | ROBERTS, MELODY ANN | LIV LABS INC., IL | $563,008 | ZRG1 |
| 2024 | Contact Pathway Inhibitor to Prevent Catheter-Related Thrombosis1R44HL170881-01A1 | LORENTZ, CHRISTINA UTUCKER, ERIK IAN | ARONORA, INC., OR | $493,999 | ZRG1 |
| 2024 | A Feasibility and Efficacy Study of NeuroTrainer Cognitive Training in Students With and Without Attention-Related Difficulties1R43MH135599-01A1 | NYQUIST, JEFFSCHWEITZER, JULIE B. | NEUROTRAINER INC, CA | $489,314 | ZRG1 |
| 2024 | Scaling Effective Behavioral Interventions with MPC Avatar-Based Virtual Training2R44HD094406-02A1 | FIRPO-TRIPLETT, REGINA | DFUSION, INC., CA | $474,877 | ZRG1 |
| 2024 | Dialyzing at home with a new model of the Wearable Artificial Kidney1R44DK139891-01 | GURA, VICTOR | WEARABLE ARTIFICIAL ORGANS, INC., CA | $459,824 | ZRG1 |
| 2024 | Development and Evaluation of a Novel Digital Therapeutic for Adults with Post-Traumatic Stress Disorder1R44MH136888-01 | FEUERSTEIN, SETHSIMON, PATRICIA | OUI THERAPEUTICS, INC, CT | $440,092 | ZRG1 |
| 2024 | Clinical development of a colon-targeted butyrate tablet to evaluate effects on cholesterol and trimethyl amine oxide in subjects at risk for cardiovascular disease1R43HL174321-01A1 | SZEWCZYK, JERZY | BIOKIER, INC., NC | $435,882 | ZRG1 |
| 2024 | Development of an In-Home Sensory Training Therapy to Mitigate Falls Risk Among the Elderly1R44AG087868-01 | YOO, HERBERT | SENAPTEC INC., OR | $407,479 | ZRG1 |
| 2024 | Guided group telehealth to deliver evidence-based therapeutic care to Black college students1R43MD020009-01 | TETTERTON, PHD, VERONICA | THE SWEET I AM, PLLC, TX | $406,092 | ZRG1 |
| 2024 | Feasibility, Pilot, and Communication studies towards Translation of Aurie Reusable Catheter System into Clinical Practice.1R44DK139913-01 | PAUL, SOUVIK | CATHBUDDY, INC., NY | $404,988 | ZRG1 |
| 2024 | A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients1R44CA291622-01A1 | SCHULER, AARON DZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC., WA | $400,000 | ZRG1 |
| 2024 | Treating stress and anxiety in individuals with alcohol use disorder (AUD) using a combination of TRPV-1 channel and C-tactile fiber activation with measurement of oxytocin and cortisol levels1R43AA031638-01 | CHABAL, CHARLES | SOOVU LABS INC, WA | $385,000 | ZRG1 |
| 2024 | Optimizing and testing the care.coach avatar as a personalized, engaging and adaptive virtual health assistant for maximizing functional and quality of life outcomes in autistic young adults1R44MH134719-01A1 | KERSSENS, CHANTAL M | CARE.COACH CORPORATION, CA | $361,412 | ZRG1 |
| 2024 | SoleStim Neuromodulation System, a home-use device for the treatment of dysmenorrhea1R43HD115425-01 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $343,510 | ZRG1 |
| 2024 | Bridges: A digital intervention to increase workplace belonging1R43MD019197-01 · under PA-22-177 | EVERS, KERRY | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $324,381 | ZRG1 |
| 2024 | Development of a Virtual Health Care Platform to reduce emergency re-hospitalizations in Heart Failure Patients transitioning from hospital to home1R43HL174224-01A1 | RAKHIT, ASHOK | NUCLEUSRX, INC., NJ | $321,363 | ZRG1 |
| 2024 | Galvanic Vestibular Stimulation to mitigate episodic Vertigo1R43DC021913-01 | HIRSCHMAN, GORDON BMCCASLIN, DEVIN LOCHLAN | VIVONICS, INC., MA | $319,120 | ZRG1 |
| 2024 | A Hybrid Program to Prevent Substance Use Risk among Upper Elementary School Students Using a Positive Youth Development Approach1R44DA061665-01 | WILLIAMS, CHRISTOPHER | NATIONAL HEALTH PROMOTION ASSOCIATES, NY | $305,046 | ZRG1 |
| 2024 | Effective Newborn Community-Outreach Recovery Engagement (ENCORE) - a culturally appropriate professional development course for community health workers1R43MD019206-01 · under PA-22-177 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $297,083 | ZRG1 |
| 2024 | Innovating Technology Solutions for Residents in Supportive Housing Communities with SUD through Community-Engaged Research1R43DA060718-01 | CIOFFI, CAMILLE CSMITH, DAVID RANDOLPHSNOW-HILL, NYSSA | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $295,924 | ZRG1 |
| 2024 | Development and Evaluation of Technology and Safety Supports for Individuals with Intellectual and Developmental Disabilities to Independently Use Driverless and Driver Supported Ridehailing Services1R44HD113503-01A1 | DAVIES, DANIEL K | ABLELINK SMART LIVING TECHNOLOGIES LLC, CO | $295,919 | ZRG1 |
| 2024 | Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients1R43DA060717-01 | ROSLYAKOV, STANISLAV | ADDINEX TECHNOLOGIES, INC., NY | $295,906 | ZRG1 |
| 2024 | Clinical Testing and Refinement of BumptUp®: A mobile health app to increase physical activity and improve obstetric outcomes among pregnant and postpartum women1R43HD115442-01 | TINIUS, RACHEL ANN | BUMPTUP LABS, INC., KY | $295,883 | ZRG1 |
| 2024 | Cogito: A turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics1R43DA060729-01 | GRABINSKI, MICHAEL JOHN | SQUARE2 SYSTEMS, INC., NH | $295,516 | ZRG1 |
| 2024 | BRITE 2.0: A just-in-time adaptive intervention for suicide safety planning in adolescents1R44MH135605-01 · under PA-22-177 | ALLEN, NICHOLAS B | KSANA HEALTH, INC., OR | $295,504 | ZRG1 |
| 2024 | Assist-MH digital technologies to support school mental health care1R43MH138260-01 | DEROSIER, MELISSA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $295,234 | ZRG1 |
| 2024 | OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Experiencing Substance Misuse.1R43DA059979-01A1 | SANSBURY, KELLY BROCK | OUR RELATIONSHIP LLC, FL | $293,467 | ZRG1 |
| 2024 | Mindfulness Meditation and Respiration Biosignal Feedback1R44MH134709-01A1 | CRESWELL, JOHN DAVIDPOLOWITZ, MATHEW | EQUA HEALTH, INC., PA | $291,447 | ZRG1 |
| 2024 | Evidence-based Parent Training for Diverse Families (PTDF)1R44HD106855-01A1 | GOLDBERG, ABBIE ELIZABETHPENNEFATHER, JORDANWENDT, ADAM JOHN | IRIS MEDIA, INC., OR | $283,526 | ZRG1 |
| 2024 | SPIRIT Club CBI Pathway: A novel streaming platform for physical activity and wellness promotion for chronic brain injury survivors1R44HD112248-01A1 · under PA-22-177 | CINER, JARED PHILLIP | SPIRIT FIT & HEALTH INC, MD | $275,699 | ZRG1 |
| 2024 | Development of an Environmental Health Literacy Mobile Application to Reduce Toxic Environmental Exposures in Black Communities1R43MD018950-01A1 | HUA, JENNA | MILLION MARKER WELLNESS INC., CA | $272,365 | ZRG1 |
| 2023 | Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP)1R44EY035596-01 · under PA-22-177 | CAMPBELL, JOHN PETERJONAS, KARYN | SILOAM VISION, INC., OR | $1,907,135 | ZRG1 |
| 2023 | The first clinical use of the BiVACOR Total Artificial Heart1R44HL167582-01A1 · under PA-22-177 | TIMMS, DANIEL | BIVACOR, INC., TX | $1,569,477 | ZRG1 |
| 2023 | Advanced Contingency Management System for Reduction of Alcohol Use.1R44AA030948-01 · under PA-22-177 | JOHNSON, RON KIMBERLYMCDONELL, MICHAEL GMCPHERSON, STERLING M | MANAGED HEALTH CONNECTIONS, LLC, WA | $1,398,716 | ZRG1 |
| 2023 | Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleotide Salvage Pathway to Treat Underserved Tumor Types1R44CA281485-01 · under PA-22-177 | SCHULTZ, KENNETH | TRETHERA CORPORATION, CA | $1,349,805 | ZRG1 |
| 2023 | Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter1R44HL169112-01A1 · under PA-22-177 | CURLEY, MICHAEL G | THERMEDICAL, INC., MA | $1,342,339 | ZRG1 |
| 2023 | Development of the Couplet Care Bassinet to support safe implementation of skin-to-skin contact and rooming-in on postnatal units2R44HD097017-02A1 · under PA-22-177 | MCENTYRE, STACIETOMORI, CECILIATULLY, KRISTIN PATRICIA | COUPLET CARE, LLC, NC | $1,341,487 | ZRG1 |
| 2023 | Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment1R44CA281622-01 · under PA-22-177 | HANNA, GABI | LAMASSU BIO INC, NC | $1,304,141 | ZRG1 |
| 2023 | Noninvasive prediction of skin precancer severity using in vivo cellular imaging and deep learning algorithms.1R44CA285138-01 · under PA-22-177 | SANCHEZ, GABRIEL NESTOR | ENSPECTRA HEALTH, INC., CA | $1,291,948 | ZRG1 |
| 2023 | Automated Long-Term Oxygen Therapy Control System2R44HL160356-02A1 · under PA-22-177 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $1,279,500 | ZRG1 |
| 2023 | An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)1R44CA281615-01 · under PA-22-177 | BROWN, DENNIS | KINTARA THERAPEUTICS, INC., CA | $1,254,180 | ZRG1 |
| 2023 | Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants1R44DC020684-01A1 · under PA-22-177 | KOCH, DEAN RMAITRE, NATHALIE | THRIVE NEUROMEDICAL, LLC, OH | $1,191,469 | ZRG1 |
| 2023 | LIGHTSITE IIIB: Clinical Evaluation of Photobiomodulation (PBM) in dry AMD Patients2R44EY025508-04 · under PA-21-260 | TEDFORD, CLARK E | LUMITHERA, INC., WA | $1,169,339 | ZRG1 |
| 2023 | The Development of a Bimodal Walking-Running Prosthetic Foot1R44HD113432-01 · under PA-22-177 | JOHANSSON, JENNIFER LYNNE | LIBERATING TECHNOLOGIES, INC., MA | $1,142,863 | ZRG1 |
| 2023 | Cognitive Behavioral Immersion: A Randomized Control Trial of Peer-Based Coaching in the Metaverse2R44MH132202-02A1 · under PA-22-177 | ROBINSON, NOAH | VERY REAL HELP, LLC, TN | $1,125,395 | ZRG1 |
| 2023 | Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs.1R44DK137730-01 · under PA-22-177 | MEHTA, MANAV | GEL4MED, INC., MA | $1,119,996 | ZRG1 |
| 2023 | Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy1R44DK136492-01A1 · under PA-22-177 | ABDI, SALAHADINKIMLESS, DEBRAWALLACE, MARK S | PURE GREEN PHARMACEUTICALS, INC., MI | $1,118,712 | ZRG1 |
| 2023 | Access-H20: Sensor driven smart faucet to enable and empower independent drinking and grooming for individuals impacted by spinal cord injury2R44HD108061-02 · under PA-22-177 | JENG, HUEIWANG ANNA COOKWADDELL, JOHN STEVEN | NASONI LLC, VA | $1,068,492 | ZRG1 |
| 2023 | SmartAssist™: Adaptive robotic assistance to maximize patient engagement with the Barrett Upper-Extremity Robotic Trainer (Burt)1R44HD109106-01A1 · under PA-22-177 | BLACK-SCHAFFER, RANDIEMCDONALD, CRAIG | BARRETT TECHNOLOGY, LLC, MA | $1,049,104 | ZRG1 |
| 2023 | SIBTime: Media-enhanced Technology for Promoting the Behavioral Health and Family Relationships of Typically Developing Young Siblings2R44MD015947-02 · under PA-22-177 | MARQUEZ, JESSIEMETZLER, CAROL WVADASY, PATRICIA F | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $1,029,677 | ZRG1 |
| 2023 | A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort2R44ES034312-02 · under PA-22-177 | HUA, JENNA | MILLION MARKER WELLNESS INC., CA | $1,028,322 | ZRG1 |
| 2023 | Development and evaluation of a multi-media training program for elementary school bullying and abuse prevention: radKIDS 2.02R44MD015695-02 · under PA-22-177 | JOHNSON-SHELTON, DEBORAH | SAAVSUS, INC., OR | $1,011,502 | ZRG1 |
| 2023 | R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes1R44DK137649-01 · under PA-22-177 | FANGER, GARYFURLAN FREGUIA, CHRISTIAN | RISE THERAPEUTICS, LLC, MD | $1,000,000 | ZRG1 |
| 2023 | A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis1R44CA288166-01 · under PA-22-177 | ISAACMAN, STEVEN | NANOMETICS, LLC, CA | $1,000,000 | ZRG1 |
| 2023 | 7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors1R44CA285207-01 · under PA-22-177 | LEWIS, LIONEL DAVIDMARATHI, UPENDRASCHARY, WILLIAM | 7 HILLS PHARMA, LLC, TX | $999,200 | ZRG1 |
| 2023 | Bloomer Augmented Garment Platform-Barrier Removal for women in cArdiac rehab (BRA)1R44HL169065-01 · under PA-22-177 | CHONG, ALICIA | BLOOMER HEALTH TECH INC, MA | $998,904 | ZRG1 |
| 2023 | Contact Pathway Inhibitor to Prevent Vascular Access Failure1R44HL167467-01 · under PA-21-260 | LORENTZ, CHRISTINA UTUCKER, ERIK IAN | ARONORA, INC., OR | $998,549 | ZRG1 |
| 2023 | Non-surgical treatment option for pelvic organ prolapse2R44HD097809-04A1 · under PA-22-177 | HANISSIAN, PAUL | REIA, LLC, NH | $994,718 | ZRG1 |
| 2023 | Mindfulness Based Stress Reduction App for African American Caregivers2R44AG071168-02 · under PA-22-177 | ALEXANDER, KARENCARSWELL, STEVEN BERNARD | COG ANALYTICS, LLC, MD | $992,382 | ZRG1 |
| 2023 | A Web-based Digital Health Portal for Practitioners to Improve Clinical Care and Patient Outcomes for Upper-limb Myoelectric Prosthesis Wearers1R44HD110334-01A1 · under PA-22-177 | WRIGHT, ZACHARY | COAPT, LLC, IL | $986,865 | ZRG1 |
| 2023 | Respiratory Oxygen Adherence Monitor for COPD Patients2R44HL147667-02A1 · under PA-22-177 | KREPKOVICH, EILEEN T. | BARRON ASSOCIATES, INC., VA | $939,577 | ZRG1 |
| 2023 | Development of ALM-488 for nerve and ureter visualization during abdominal surgery1R44CA275546-01A1 · under PA-22-177 | BERMAN, BRETT J.WHITNEY, MICHAEL A | ALUME BIOSCIENCES, INC., CA | $937,219 | ZRG1 |
| 2023 | An online professional development course to train CHWs to provide oral health outreach to low-income Black guardians2R44MD016352-02 · under PA-22-177 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $933,473 | ZRG1 |
| 2023 | A conversational agent to support remote care for individuals with substance use disorder2R44DA050218-02 · under PA-22-177 | HO, Y. XIANJACKSON, JONATHAN LEE | DIMAGI, INC., MA | $927,938 | ZRG1 |
| 2023 | Phase IIB Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease2R44AG047722-07 · under PA-21-260 | LEE, HYUN KYU | POSIT SCIENCE CORPORATION, CA | $924,904 | ZRG1 |
| 2023 | Spinal Cord Innovation in Pediatrics to Treat Cerebral Palsy (SCiP Clinical Study)1R44HD112281-01A1 · under PA-22-177 | GAD, PARAG | SPINEX, INC., CA | $924,592 | ZRG1 |
| 2023 | Intuitive Child Safety Seat to Increase Security2R44HD097846-02 · under PA-22-177 | SEIFERT, SARA | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $922,259 | ZRG1 |
| 2023 | Mucoadhesive film for the treatment of vestibulodynia1R44HD112245-01 · under PA-22-177 | BENHABBOUR, SOUMYA RAHIMAGELLER, ELIZABETHGUTHRIE, KATE MJANUSZIEWICZ, RIMA | ANELLEO, INC., NC | $891,877 | ZRG1 |
| 2023 | XCSITE 300: Cloud-Enabled Closed-Loop Transcranial Current Stimulation Device for At-Home Studies2R44MH119872-03 · under PA-22-177 | TOWNSEND, LEAH BISHOP | PULVINAR NEURO LLC, NC | $886,440 | ZRG1 |
| 2023 | Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy (KneeBRIGHT)2R44AG062069-04A1 · under PA-21-260 | KREPKOVICH, EILEEN T. | BARRON ASSOCIATES, INC., VA | $885,288 | ZRG1 |
| 2023 | Amino Acids and Pediatric Hepatic Steatosis1R44DK135312-01A1 · under PA-22-177 | WOLFE, ROBERT R | AMINO COMPANY LLC, THE, DE | $883,007 | ZRG1 |
| 2023 | Regulatory clearance of the Glide Control Strategy for Upper Limb Prostheses2R44HD090811-04A1 · under PA-21-260 | KALIKI, RAHUL REDDY | INFINITE BIOMEDICAL TECHNOLOGIES, LLC, MD | $873,316 | ZRG1 |
| 2023 | Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes2R44MH114763-02A1 · under PA-21-260 | STERNS, ANTHONY | IRX REMINDER, LLC, OH | $871,153 | ZRG1 |
| 2023 | Developing and testing the Opioid Rapid Response System2R44DA053078-02 · under PA-22-177 | CHOI, HYE JEONGHECHT, MICHAEL | REAL PREVENTION, LLC, NJ | $858,761 | ZRG1 |
| 2023 | Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients1R44HL167591-01A1 · under PA-21-260 | GUPTA, DIPANKARSEIGUER, SEBASTIAN | EMOCHA MOBILE HEALTH, INC., MD | $838,636 | ZRG1 |
| 2023 | Novel Post-surgical Incision Management Device to Prevent Ostomy Complications1R44DK131766-01A1 · under PA-21-260 | OBST, ANDREW T | FISTULA SOLUTION CORPORATION, MN | $773,063 | ZRG1 |
| 2023 | GEMINI: Virtual Integrative Medical Group Visits for Managing Chronic Pain1R44AT012302-01A1 · under PA-22-177 | GARDINER, PAULA MARIEHAAS, NIINA M. | BRIGHTOUTCOME INC., IL | $747,191 | ZRG1 |
| 2023 | Transforming Hospitalizations of Autistic Adolescents via a Novel ABA Telehealth Platform1R44MH134706-01 · under PA-22-177 | OBERLEITNER, RONALD | CARING TECHNOLOGIES, INC., ID | $740,782 | ZRG1 |
| 2023 | Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme1R44CA275508-01A1 · under PA-22-177 | MARCUS, STUART | SONALASENSE INC, CA | $694,814 | ZRG1 |
| 2023 | Reducing Hypertension among African American Men: A Mobile Stress Management Intervention to Address Health Disparities2R44MD017106-02 · under PA-22-177 | LEAF, SAMANTHA L. | ISA ASSOCIATES, INC., VA | $693,481 | ZRG1 |
| 2023 | Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant1R44CA285177-01 · under PA-22-177 | ANGELO, LAURA SVERA, JUAN FERNANDO | MARKER THERAPEUTICS, INC., TX | $664,838 | ZRG1 |
| 2023 | Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program2R44DA053081-02 · under PA-22-177 | HALLGREN, KEVIN A.SEIGUER, SEBASTIANTSUI, JUDITH | EMOCHA MOBILE HEALTH, INC., MD | $654,494 | ZRG1 |
| 2023 | ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)1R44HL169085-01 · under PA-22-177 | CREARY, SUSANSEIGUER, SEBASTIAN | EMOCHA MOBILE HEALTH, INC., MD | $642,844 | ZRG1 |
| 2023 | SBIR, Innovative Immersive Technologies for Evidence-Based Violence Prevention among College Students2R44CE003173-02A1 · under PA-22-177 | WILLIAMS, CHRISTOPHER | NATIONAL HEALTH PROMOTION ASSOCIATES, NY | $615,917 | ZRG1 |
| 2023 | Digital Delivery of Evidence-Based Mental Health Content and Mentoring to Adolescents1R44MH134733-01 · under PA-22-177 | PULLMANN, MICHAEL DAVIDROUNDFIELD, KATRINA | APPA HEALTH INC, CA | $558,383 | ZRG1 |
| 2023 | Home Monitoring of Metabolic Disorders1R44HD112243-01 · under PA-22-177 | THOMAS, MARYLAURA LIND | SEQUITUR HEALTH CORP., AZ | $542,100 | ZRG1 |
| 2023 | A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis1R44AG084484-01 · under PA-22-177 | FANGER, GARY | RISE THERAPEUTICS, LLC, MD | $494,488 | ZRG1 |
| 2023 | Advanced CLAD PERG system with minimal patient preparation for clinical settings (Phase II)2R44EY029620-02A1 · under PA-22-177 | TOFT-NIELSEN, JONATHON ANTHONY | JORVEC CORPORATION, FL | $479,128 | ZRG1 |
| 2023 | Development of an empathetic chatbot to monitor perinatal mental health longitudinally1R43MH130293-01A1 · under PA-21-260 | KERPPOLA, MARIANNAMUZIK, MARIA | POISERA, INC., MI | $431,081 | ZRG1 |
| 2023 | Technology Assisted Treatment for Binge Eating Behavior1R43MH132180-01 · under PA-21-260 | KUMAR, SAMEERPETERSON, CAROL B. | HABITAWARE, INC., MN | $420,178 | ZRG1 |
| 2023 | A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)1R44CA278187-01A1 · under PA-22-177 | SCHULER, AARON DZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC., WA | $400,000 | ZRG1 |
| 2023 | On Demand Oral Contraception for Obese Women1R43HD107861-01A1 · under PA-22-177 | ARCHER, DAVID FITZGERALD | INNOVAGYN, INC., VA | $382,402 | ZRG1 |
| 2023 | SafeMedWaste At-Home, Environmentally-Friendly Opioid Disposal Kit for Orthopedic Post-Operative Surgical Patients to Reduce Opioids Available for Diversion1R43DA057750-01A1 · under PA-22-177 | JACKSON, J. BENJAMINSTAS, JUSTIN | OKRA MEDICAL, INC., SC | $323,698 | ZRG1 |
| 2023 | iKinnect Mobile Technology to Reduce Teen Substance Misuse and Health Disparities1R44DA057122-01 · under PA-21-260 | DIMEFF, LINDA ASCHAEFFER, CINDY M. | EVIDENCE-BASED PRACTICE INSTITUTE, INC., WA | $319,737 | ZRG1 |
| 2023 | Otis Brux-Sensor Night Guard - a novel wireless custom night guard system with pressure sensors to quantitatively measure bite compression forces and alleviate sleep bruxism1R43HL168988-01A1 · under PA-22-177 | BERANEK, RICHARDLEE, ANDREW | OTIS DENTAL, LLC, CA | $299,753 | ZRG1 |
| 2023 | Using Digital Health Technology to Prevent Bullying and Cyberbullying among Elementary School Students1R44HD114361-01 · under PA-22-177 | WILLIAMS, CHRISTOPHER | NATIONAL HEALTH PROMOTION ASSOCIATES, NY | $296,231 | ZRG1 |
| 2023 | Beat Extreme: An Interactive, Tailored Text Messaging Program Combining Extreme Weather Alerts with Hyper-localized Resources & Actionable Insights for Addressing Climate Change1R43ES035344-01 · under PA-22-177 | JOHNSON, SARA S | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $295,923 | ZRG1 |
| 2023 | Apto-Ankle: Passive, Compliant Ankle with Enhanced Energy Storage and Return in Gait1R43HD114307-01 · under PA-22-177 | ARABIAN, ADAM KAREKIN | ORTHOCARE INNOVATIONS, LLC, WA | $293,514 | ZRG1 |
| 2023 | Promoting Parallel Parenting: Putting Children First during High-Conflict Divorce and Separation (PCF)1R44HD111084-01A1 · under PA-22-177 | JONES, JEREMY AUSTINPENNEFATHER, JORDANRUDD, BRITTANY NWENDT, ADAM JOHN | IRIS MEDIA, INC., OR | $288,072 | ZRG1 |
| 2023 | A ratcheting pediatric prosthetic finger using advanced rapid manufacturing technology1R44HD113485-01A1 · under PA-22-177 | SLIKER, LEVIN | POINT DESIGNS, LLC, CO | $275,764 | ZRG1 |
| 2023 | Rumbo: An Integrated Mobile and Web-Based Application to Overcome Barriers to Receive Substance Use Disorder (SUD) Treatment and Improve Outcomes for Spanish-Speaking, Hispanic and Latinx Individuals1R43DA057759-01 · under PA-21-260 | CAMPBELL, WILLIAM P | VOLVER HEALTH LLC, NM | $275,743 | ZRG1 |
| 2023 | Clarity in Motion: A Motion-Tolerant Aid for Selectively Hearing Acoustic Sources1R43DC020690-01A1 · under PA-21-260 | GOLDHOR, RICHARD S | SPEECH TECHNOLOGY/APPLIED RESEARCH CORP., MA | $275,389 | ZRG1 |
| 2023 | Voice-based AI to scale evaluation of crisis counseling in 988 rollout1R44MH133517-01 · under PA-22-177 | ATKINS, DAVID CHARLES | LYSSN.IO, INC., WA | $275,373 | ZRG1 |
| 2023 | DEVELOPMENT OF A NOVEL PEER RECOVERY SUPPORTER TRAINING PLATFORM TO DISSEMINATE EVIDENCE-BASED TRAINING AT SCALE1R44AA030953-01A1 · under PA-22-177 | PESCE, CHRISTOPHER NEIL | THRIVE DIGITAL HEALTH, LLC, OH | $275,301 | ZRG1 |
| 2023 | Biomechanical Evaluation of a Novel, Compliant Low Profile Prosthetic Foot1R43HD110316-01A1 · under PA-22-177 | BARTLETT, HARRISON LOGAN | LITTLE ROOM INNOVATIONS, LLC, MI | $275,197 | ZRG1 |
| 2023 | Tele-FootX: Virtually Supervised Tele-Exercise Platform for Accelerating Plantar Wound Healing1R43AG082614-01 · under PA-22-177 | NAJAFI, BIJANVAZIRI, ASHKAN | BIOSENSICS, LLC, MA | $275,000 | ZRG1 |
| 2023 | A Translational Research Approach to Healthy Technology Usage in Language-Minority Families with Young Children1R44HD114323-01 · under PA-22-177 | TURCO, ROSA GUZMAN | TRANSCENDENT INTERNATIONAL, LLC, NY | $274,996 | ZRG1 |
| 2023 | Development and Evaluation of the PPAL Bedside Commode for Safe Independent Toileting Transfers2R44NR019516-02A1 · under PA-22-177 | GRAHAM, MARGARET ELLEN | QUA, INC., NY | $273,056 | ZRG1 |
| 2023 | Previvors Recharge: A Resilience Program for Cancer Previvors1R43CA275673-01A1 · under PA-22-177 | EVERS, KERRY | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $265,253 | ZRG1 |
| 2023 | Fast-Track Multimodal monitoring for neonatal neurocritical care1R44HD107729-01A1 · under PA-21-260 | CARNES, TONY CHRIS | MEDITRACE LLC, FL | $260,434 | ZRG1 |
| 2023 | Humidifeye Plug for Dry Eye Disease1R44EY034758-01 · under PA-21-260 | BAYAT, NIKI | AESCULATECH, INC., CA | $250,487 | ZRG1 |
| 2023 | LIMBER UniLeg: A digital and additive manufacturing approach for accessible prosthetic care.1R43HD112285-01A1 · under PA-22-177 | BARRACK, HERBERT JOSEPH | LIMBER PROSTHETICS & ORTHOTICS INC., CA | $247,429 | ZRG1 |
| 2022 | Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder2R44AA024905-06 · under PA-20-262 | TABAKOFF, BORIS | LOHOCLA RESEARCH CORPORATION, CO | $1,710,532 | ZRG1 |
| 2022 | Augmented Reality Real-Time Guidance for MRI-Guided Interventions2R44EB028722-02A1 · under PA-21-260 | RAJAN, PURNIMA | CLEAR GUIDE MEDICAL, INC., MD | $1,561,929 | ZRG1 |
| 2022 | Labor Status Monitor for diagnosing True versus False Labor in preterm patients1R44HD109107-01 · under PA-21-260 | YOUNG, ROGER C. | PRETEL, INC., TN | $1,375,524 | ZRG1 |
| 2022 | Assessing the Utility of Submaximal Cardiopulmonary Exercise Testing in Diagnosis and Treatment Management of Pulmonary Arterial Hypertension1R44HL162169-01A1 · under PA-21-260 | MACCARTER, DEAN JUDSON | SHAPE MEDICAL SYSTEMS, INC., MN | $1,223,664 | ZRG1 |
| 2022 | Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent1R44CA277890-01 · under PA-21-260 | BENSEN, ERIC SCOTTSINGHAL, SUNIL | VERGENT BIOSCIENCE, INC., MN | $1,124,282 | ZRG1 |
| 2022 | An Open-source Speech Processing Platform (OSP) for Research on Hearing Loss and Related Disorders1R44DC020406-01 · under PA-21-260 | GARUDADRI, HARINATH | NADI LLC, CA | $1,112,006 | ZRG1 |
| 2022 | Evaluation of Subtractive Immunopheresis for Treatment of Hormone-Refractive Advanced Breast Cancer1R44CA261565-01A1 · under PA-21-260 | SHENOUDA, CHRISTIAN | IMMUNICOM, INC., CA | $1,072,330 | ZRG1 |
| 2022 | Development of Sotair for Improving Performance and Minimizing Complications of Manual Ventilation1R44HL165932-01A1 · under PA-21-260 | PRABHUDESAI, PRATHAMESH | SAFEBVM CORP., MO | $1,054,335 | ZRG1 |
| 2022 | Improving the health status of dysvascular amputees by deploying digital prosthetic interface technology in combination with exercise intervention1R44HD110327-01 · under PA-21-260 | BONATO, PAOLOTURNER, TROY | BIONIC SKINS LLC, NH | $1,052,841 | ZRG1 |
| 2022 | Active Disposable Cap for Endoscope Tip Stabilization and Complete Visualization and Dissection of Serrated Sessile Polyps2R44DK117813-06 · under PA-21-260 | MULVIHILL, MAUREEN L. | ACTUATED MEDICAL, INC., PA | $1,047,462 | ZRG1 |
| 2022 | IND‐enabling development of MM‐008 IVR, an antibody-based nonhormonal contraceptive intravaginal ring1R44HD107824-01 · under PA-20-262 | CONE, RICHARD | MUCOMMUNE, LLC, NC | $1,039,122 | ZRG1 |
| 2022 | A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults with Inoperable Relapsed or Refractory High Grade Glioma1R44CA272070-01A1 · under PA-21-260 | LONGCOR, JARRODREILLY, LAURENCE | CELLECTAR BIOSCIENCES, INC., NJ | $1,034,797 | ZRG1 |
| 2022 | Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia2R44CA254560-02 · under PA-21-260 | DILLIGAN, KATE | COOLER HEADS CARE INC, CA | $1,033,003 | ZRG1 |
| 2022 | PROGRESS: PRevention of cervical cancer using the Genotyping scREening and Same-day Self-sampling1R44CA272177-01 · under PA-21-260 | CREMER, MIRIAMWANG, YOUXIANG | ATILA BIOSYSTEMS, INC., CA | $1,011,310 | ZRG1 |
| 2022 | StrokeWear: A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life.2R44HD084035-04 · under PA-21-260 | BONATO, PAOLOKEYSOR, JULIE JVAZIRI, ASHKAN | BIOSENSICS, LLC, MA | $1,008,134 | ZRG1 |
| 2022 | A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location1R44AG076248-01A1 · under PA-21-260 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $1,004,449 | ZRG1 |
| 2022 | Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer1R44CA265626-01A1 · under PA-21-260 | LI, YAJUANTWEEDLE, MICHAEL F | MOLECULAR THERANOSTICS, LLC, OH | $1,000,000 | ZRG1 |
| 2022 | Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients1R44CA272096-01 · under PA-21-260 | DEISHER, THERESA | AVM BIOTECHNOLOGY, LLC, WA | $999,999 | ZRG1 |
| 2022 | Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia1R44CA268530-01A1 · under PA-21-260 | BREITFELD, PHILIPVARADHACHARY, ATUL | FANNIN PARTNERS, LLC, TX | $999,997 | ZRG1 |
| 2022 | Ceraxa (Ceramide NanoLiposome) and Vinblastine For the Improved Treatment of Relapsed or Refractory Acute Myeloid Leukemia1R44CA275609-01 · under PA-21-260 | ADAIR, BERNADETTE MCMAHON | KEYSTONE NANO, INC., PA | $999,628 | ZRG1 |
| 2022 | A treatment drug for triple negative breast cancer1U44CA268345-01A1 · under PA-21-260 | LIU, ZHI-REN | PRODA BIOTECH, LLC, GA | $999,562 | ZRG1 |
| 2022 | The HOPE App: An Immersive Telehealth Solution for Older Adults with Diabetes2R44AG072990-02 · under PA-21-260 | MITCHELL, SUZANNE | SEE YOURSELF HEALTH, LLC, MA | $997,968 | ZRG1 |
| 2022 | Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System1R44DK133084-01 · under PA-21-260 | DEJOURNETT, LEON | IDEAL MEDICAL TECHNOLOGIES, INC., NC | $958,212 | ZRG1 |
| 2022 | Evaluation of the safety and efficacy of non-invasive sonodynamic therapy for diffuse intrinsic pontine glioma1R44CA261516-01A1 · under PA-20-262 | MARCUS, STUART | SONALASENSE INC, CA | $938,955 | ZRG1 |
| 2022 | Knowledge and Usage of Lactation using Education and Advice from Support Network (KULEA-NET)1R44MD016829-01A1 · under PA-21-260 | EVANS, W. DOUGLASMA, TONY XUYENPATCHEN, LORAL | BENTEN TECHNOLOGIES, INC., VA | $915,801 | ZRG1 |
| 2022 | PeriPath: A Single Incision Delivery Tool for Epicardial Pacing and Defibrillation: Phase 21R44HL166048-01 · under PA-21-260 | BERUL, CHARLES IOPFERMANN, JUSTIN | PERICOR, LLC, MD | $914,055 | ZRG1 |
| 2022 | Citizen-Science Technology for Healthy Living at Home2R44MD014915-02 · under PA-21-260 | CARTER, ELLISON MREILLY, THOMAS | ACCESS SENSOR TECHNOLOGIES, LLC, CO | $882,648 | ZRG1 |
| 2022 | Technology Assisted Treatment for Trichotillomania2R44MH114773-03 · under PA-20-262 | FLESSNER, CHRISTOPHER A.KUMAR, SAMEER | HABITAWARE, INC., MN | $879,144 | ZRG1 |
Showing the 200 most recent of 458 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.